T41.3
Conditions
Interventions
Group 1: Retrospective analysis of registry data on adult patients who underwent a postoperative regional analgesia catheter procedure. The registry data include routine clinical data from protocol-ba
Sponsors
Klinik für Anästhesiologie, Universitätsmedizin Mainz
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: • No concurrent participation in another study • Regional analgesia procedure with acute pain management support since June 2024 (start of internal electronic registry data collection)
Exclusion criteria
Exclusion criteria: none outside the inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of daily ropivacaine doses exceeding 800 mg in adult acute pain patients receiving postoperative regional analgesia via catheter on at least one of the postoperative care days (data collected from an internal hospital registry database containing routine clinical data) | — |
Secondary
| Measure | Time frame |
|---|---|
| - Occurrence of LAST signs - Occurrence of other potential drug side effects, such as nausea, dizziness, and fatigue - Associations with ASA status, duration of surgery, surgical specialty/procedure, pre-existing conditions, functional impairment, hypoalbuminemia, and bilateral catheter placement | — |
Countries
Germany
Contacts
Public ContactKatrin Fries
Klinik für Anästhesiologie
Outcome results
None listed